We are live on
!
Find out more
AH
Aviva Holdings Portfolio holdings
AUM
$20.5M
1-Year Est. Return
117.01%
This Fund
S&P 500
This Quarter
Est. Return
+29.98%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$478M
AUM Growth
+$22.3M
(+4.9%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-22.56%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inseego
INSG
|
+$14.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$91.3M |
| 2 |
ESPR
Esperion Therapeutics
ESPR
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 75.07% |
| 2 | Technology | 22.01% |
| 3 | Miscellaneous | 2.92% |
Similar funds
MFAM
SL
CIM
SFM
SFG
CGI
VFA
AMG
Aviva Holdings's Q2 2019 Portfolio in Review
As of Q2 2019, Aviva Holdings held 6 positions worth $478M, up 4.9% from $456M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Aviva Holdings withdrew a net $108M in Q2 2019, closing 1 position and reducing 1 holding. Its most notable exit was Esperion Therapeutics, an estimated $17.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 78% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Aviva Holdings added an estimated $14.9M to Inseego.
- Aviva Holdings added most to Inseego in Q2 2019, an estimated $14.9M increase.
- Aviva Holdings's biggest Q2 2019 reduction was Medicines Co, cutting an estimated $91.3M.
- Aviva Holdings fully exited Esperion Therapeutics in Q2 2019, selling an estimated $17.7M.
- Aviva Holdings's ten largest holdings make up 100% of its $478M portfolio in Q2 2019.
- Aviva Holdings opened 0 new positions and closed 1 in Q2 2019.
- Aviva Holdings's portfolio value rose 4.9% quarter-over-quarter to $478M.
Based on Aviva Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.